This review presents and discusses evidence demonstrating the importance of mitochondria and related processes in the pathogenesis of Alzheimer's disease. Mitochondrial dysfunction is currently emerging as a potential therapeutic target in the treatment of Alzheimer's disease and other neurodegenerative diseases. This paper also reviews various drug strategies aimed at mitochondrial dysfunction and the development of oxidative stress
Mitochondria are crucial regulators of energy metabolism and apoptotic pathways and have been closel...
There is substantial evidence of morphological, biochemical and molecular abnormalities in mitochond...
There is substantial evidence of morphological, biochemical and molecular abnormalities in mitochond...
AbstractAlzheimer's disease (AD) remains the most common neurodegenerative disease characterized by ...
Mitochondrial dysfunction is now recognized as a contributing factor to neurodegenerative diseases, ...
Abstract It is widely recognized that Alzheimer's disease (AD) is a common type of progressive neuro...
Alzheimer’s disease (AD) is a common form of dementia, affecting millions of people worldwide, mostl...
Alzheimer’s disease (AD) is a common form of dementia, affecting millions of people worldwide, mostl...
Alzheimer’s disease (AD) is a common form of dementia, affecting millions of people worldwide, mostl...
Alzheimer's disease (AD) is the most common form of dementia in the elderly. This neurodegenerative ...
Alzheimer’s disease (AD) is the most common cause of dementia worldwide and is characterised patholo...
Alzheimer's disease (AD) is an increasingly pressing worldwide public-health, social, political and ...
AbstractAlzheimer's disease (AD) remains the most common neurodegenerative disease characterized by ...
Alzheimer’s disease (AD), a chronic and progressive neurodegenerative disease, is characterized by m...
AbstractMitochondria are uniquely poised to play a pivotal role in neuronal cell survival or death b...
Mitochondria are crucial regulators of energy metabolism and apoptotic pathways and have been closel...
There is substantial evidence of morphological, biochemical and molecular abnormalities in mitochond...
There is substantial evidence of morphological, biochemical and molecular abnormalities in mitochond...
AbstractAlzheimer's disease (AD) remains the most common neurodegenerative disease characterized by ...
Mitochondrial dysfunction is now recognized as a contributing factor to neurodegenerative diseases, ...
Abstract It is widely recognized that Alzheimer's disease (AD) is a common type of progressive neuro...
Alzheimer’s disease (AD) is a common form of dementia, affecting millions of people worldwide, mostl...
Alzheimer’s disease (AD) is a common form of dementia, affecting millions of people worldwide, mostl...
Alzheimer’s disease (AD) is a common form of dementia, affecting millions of people worldwide, mostl...
Alzheimer's disease (AD) is the most common form of dementia in the elderly. This neurodegenerative ...
Alzheimer’s disease (AD) is the most common cause of dementia worldwide and is characterised patholo...
Alzheimer's disease (AD) is an increasingly pressing worldwide public-health, social, political and ...
AbstractAlzheimer's disease (AD) remains the most common neurodegenerative disease characterized by ...
Alzheimer’s disease (AD), a chronic and progressive neurodegenerative disease, is characterized by m...
AbstractMitochondria are uniquely poised to play a pivotal role in neuronal cell survival or death b...
Mitochondria are crucial regulators of energy metabolism and apoptotic pathways and have been closel...
There is substantial evidence of morphological, biochemical and molecular abnormalities in mitochond...
There is substantial evidence of morphological, biochemical and molecular abnormalities in mitochond...